NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, today issued a letter ...

The IRF1 and IRF2 proteins contain positive-acting nuclear localization signals (NLS) located immediately C-terminal to the DNA-binding domain, involving amino acids ≈120–140 . The IRF3 protein has a ...